Corporate Governance Reporthttp://pdf.irpocket.com/C4576/PTSX/Q2Wq/ZvSB.pdf<a href="http://pdf.irpocket.com/C4576/PTSX/Q2Wq/ZvSB.pdf">Corporate Governance Report</a><a href="http://pdf.irpocket.com/C4576/PTSX/Q2Wq/ZvSB.pdf">Corporate Governance Report</a>2024-03-27T15:35:00+09:00Submitted Clinical Trial plan Notification for regenerative medicine cell product DWR-2206http://pdf.irpocket.com/C4576/nGVW/I35f/z5Kh.pdf<a href="http://pdf.irpocket.com/C4576/nGVW/I35f/z5Kh.pdf">Submitted Clinical Trial plan Notification for regenerative medicine cell product DWR-2206</a><a href="http://pdf.irpocket.com/C4576/nGVW/I35f/z5Kh.pdf">Submitted Clinical Trial plan Notification for regenerative medicine cell product DWR-2206</a>2024-03-27T15:00:00+09:00Analyst Report / Follow-up Report (Sessa Partners Inc.)http://pdf.irpocket.com/C4576/nGVW/ROEW/PIUb.pdf<a href="http://pdf.irpocket.com/C4576/nGVW/ROEW/PIUb.pdf">Analyst Report / Follow-up Report (Sessa Partners Inc.)</a><a href="http://pdf.irpocket.com/C4576/nGVW/ROEW/PIUb.pdf">Analyst Report / Follow-up Report (Sessa Partners Inc.)</a>2024-03-18T18:00:00+09:00[Delayed]Consolidated Financial Results for the Fiscal Year Ended December 31, 2023 (Based on Japanese GAAP)http://pdf.irpocket.com/C4576/KKjE/yyzv/AenP.pdf<a href="http://pdf.irpocket.com/C4576/KKjE/yyzv/AenP.pdf">[Delayed]Consolidated Financial Results for the Fiscal Year Ended December 31, 2023 (Based on Japanese GAAP)</a><a href="http://pdf.irpocket.com/C4576/KKjE/yyzv/AenP.pdf">[Delayed]Consolidated Financial Results for the Fiscal Year Ended December 31, 2023 (Based on Japanese GAAP)</a>2024-02-14T08:45:00+09:00FY12/23 Financial Results Briefing Materialshttp://pdf.irpocket.com/C4576/KKjE/UuSh/ptLq.pdf<a href="http://pdf.irpocket.com/C4576/KKjE/UuSh/ptLq.pdf">FY12/23 Financial Results Briefing Materials</a><a href="http://pdf.irpocket.com/C4576/KKjE/UuSh/ptLq.pdf">FY12/23 Financial Results Briefing Materials</a>2024-02-09T15:30:00+09:00